Deramiocel (CAP-1002)
CAP-1002-DMD-04
Phase 3 mab active
Quick answer
Deramiocel (CAP-1002) for Muscular Dystrophies is a Phase 3 program (mab) at CAPRICOR THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CAPRICOR THERAPEUTICS, INC.
- Indication
- Muscular Dystrophies
- Phase
- Phase 3
- Modality
- mab
- Status
- active